Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202999200 on May 16, 2002

J. Biol. Chem., Vol. 277, Issue 30, 26846-26851, July 26, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/30/26846    most recent
M202999200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gladysheva, I. P.
Right arrow Articles by Reed, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gladysheva, I. P.
Right arrow Articles by Reed, G. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Chimerism Reveals a Role for the Streptokinase beta -Domain in Nonproteolytic Active Site Formation, Substrate, and Inhibitor Interactions*

Inna P. Gladysheva, Irina Y. Sazonova, Shakeel A. Chowdhry, Lin Liu, Ryan B. Turner, and Guy L. ReedDagger

From the Cardiovascular Biology Laboratory, Harvard School of Public Health and the Massachusetts General Hospital, Boston, Massachusetts 02114

Streptokinase (SK) and staphylokinase form cofactor-enzyme complexes that promote the degradation of fibrin thrombi by activating human plasminogen. The unique abilities of streptokinase to nonproteolytically activate plasminogen or to alter the interactions of plasmin with substrates and inhibitors may be the result of high affinity binding mediated by the streptokinase beta -domain. To examine this hypothesis, a chimeric streptokinase, SKbeta swap, was created by swapping the SK beta -domain with the homologous beta -domain of Streptococcus uberis Pg activator (SUPA or PauA, SK uberis), a streptokinase that cannot activate human plasminogen. SKbeta swap formed a tight complex with microplasminogen with an affinity comparable with streptokinase. The SKbeta swap-plasmin complex also activated human plasminogen with catalytic efficiencies (kcat/Km = 16.8 versus 15.2 µM-1 min-1) comparable with streptokinase. However, SKbeta swap was incapable of nonproteolytic active site generation and activated plasminogen by a staphylokinase mechanism. When compared with streptokinase complexes, SKbeta swap-plasmin and SKbeta swap-microplasmin complexes had altered affinities for low molecular weight substrates. The SKbeta swap-plasmin complex also was less resistant than the streptokinase-plasmin complex to inhibition by alpha 2-antiplasmin and was readily inhibited by soybean trypsin inhibitor. Thus, in addition to mediating high affinity binding to plasmin(ogen), the streptokinase beta -domain is required for nonproteolytic active site generation and specifically modulates the interactions of the complex with substrates and inhibitors.


* This work was supported in part by National Institutes of Health Grant HL-57314 (to G. L. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Cardiovascular Biology Laboratory, HSPH II-127, 677 Huntington Ave., Boston, MA 02115. Tel.: 617-432-4992; Fax: 617-432-0033; E-mail: guyreed@hsph.harvard.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Y. Sazonova, B. R. Robinson, I. P. Gladysheva, F. J. Castellino, and G. L. Reed
{alpha} Domain Deletion Converts Streptokinase into a Fibrin-dependent Plasminogen Activator through Mechanisms Akin to Staphylokinase and Tissue Plasminogen Activator
J. Biol. Chem., June 11, 2004; 279(24): 24994 - 25001.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. P. Gladysheva, R. B. Turner, I. Y. Sazonova, L. Liu, and G. L. Reed
Coevolutionary patterns in plasminogen activation
PNAS, August 5, 2003; 100(16): 9168 - 9172.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement